If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Total Voting Rights

30 Dec 2016 07:00

RNS Number : 0056T
WANdisco Plc
30 December 2016
 

30 December 2016

WANdisco plc

("WANdisco" or the "Company")

 

Total voting rights

 

Notification under Rule 5.6.1 Financial Conduct Authority Disclosure and Transparency Rules:

 

The Company's issued share capital at 30 December consisted of 37,067,641 ordinary shares of 10 pence each with voting rights admitted to trading. The Company holds no ordinary shares in Treasury.

 

Therefore, the total number of voting rights in the Company is 37,067,641. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.

 

Of the total of 37,067,641 Ordinary Shares of ten pence each:

· 35,127,982 are admitted under ISIN JE00B6Y3DV84, ticker WAND; and

· 1,939,659 are Regulation S, Category 3, admitted under ISIN JE00BYPG6G89, ticker WAN2

 

For further information, please contact:

 

WANdisco plc

via Vigo Communications

David Richards, Chief Executive Officer and Interim Chairman

Erik Miller, Chief Financial Officer

Vigo Communications

+44 (0)207 830 9700

Jeremy Garcia / Fiona Henson / Antonia Pollock

www.vigocomms.com

Stifel (Joint Broker and Nomad)

+44 (0)207 710 7600

David Arch / Fred Walsh / Neil Shah

UBS (Joint Broker)

Rahul Luthra / Sandip Dhillon

+44 (0)207 567 8000

 

About WANdisco plc

WANdisco (LSE: WAND) is the world leader in Active Transactional Data Replication™. Its patented technology provides continuous consistent access to changing data anytime and anywhere with no downtime and no disruption. WANdisco's patented technology serves crucial high availability (HA) requirements, including migration to cloud, Hadoop Big Data and Application Lifecycle Management (ALM), Subversion, Git and Gerrit.

 

WANdisco works directly with Fortune 1000 companies around the world and in all sectors to ensure their data, whether it is on-premise or in the cloud, gives them the real insight they need. WANdisco has an OEM with IBM and is also partnered with Amazon Web Services, Cisco, Google Cloud Platform, Hewlett Packard Enterprise, Microsoft Azure and Oracle to resell its patented technology. WANdisco is committed to the ODPi Interoperable Compliance Program to ensure its products are interoperable across a wider range of commercial Apache™ Hadoop® Platforms.

 

For additional information, please visit www.wandisco.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUKVORNOAUUUA
Date   Source Headline
27th Apr 201711:45 amRNSDirector Dealing
24th Apr 20177:00 amRNSSignificant customer win and Q1 update
21st Apr 20177:00 amRNSPosting of Annual Report and Notice of AGM
5th Apr 20177:00 amRNSTotal Voting Rights
29th Mar 20177:00 amRNSLong Term Incentive Plan
28th Mar 20177:00 amRNSLaunch of WANdisco Fusion 2.10
8th Mar 20177:00 amRNSPreliminary Results
6th Mar 20174:40 pmRNSSecond Price Monitoring Extn
6th Mar 20174:35 pmRNSPrice Monitoring Extension
23rd Feb 20177:00 amRNSBoard Update
14th Feb 20177:00 amRNSNotice of Results and Investor Presentation
18th Jan 20174:40 pmRNSSecond Price Monitoring Extn
18th Jan 20174:35 pmRNSPrice Monitoring Extension
16th Jan 20177:00 amRNSTrading Update
30th Dec 20167:00 amRNSTotal Voting Rights
29th Dec 20166:00 pmRNSDirector Dealings
23rd Dec 20167:00 amRNSDirector Dealing
21st Dec 20163:00 pmRNSHolding(s) in Company
19th Dec 20167:01 amRNSSignificant customer win
19th Dec 20167:00 amRNSAppointment of Nomad and Joint Broker
8th Dec 20163:15 pmRNSListing Application
8th Dec 20167:00 amRNSDirector/PDMR Shareholding
8th Dec 20167:00 amRNSGrant of Share Options to Executive Directors
5th Dec 20167:00 amRNSBoard Appointments
2nd Dec 20164:06 pmRNSHolding(s) in Company
1st Dec 20167:46 amRNSTotal Voting Rights
15th Nov 20167:00 amRNSContract win
1st Nov 20167:00 amRNSTotal Voting Rights
10th Oct 20167:00 amRNSWANdisco secures two new record contracts
10th Oct 20167:00 amRNSAppointments
6th Oct 20167:01 amRNSRe-instatement of David Richards
6th Oct 20167:00 amRNSDirectorate Changes
30th Sep 20162:24 pmRNSTotal Voting Rights
29th Sep 201610:41 amRNSDirectorate Change
29th Sep 201610:30 amRNSDirectorate Change
28th Sep 20167:00 amRNSAppointment of Chief Financial Officer
1st Sep 20167:00 amRNSTotal Voting Rights
5th Aug 20167:35 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Aug 20167:00 amRNSInterim Results
1st Aug 20169:02 amRNSTotal Voting Rights
13th Jul 20163:06 pmRNSHolding(s) in Company
12th Jul 201610:11 amRNSHolding(s) in Company
8th Jul 20166:10 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Jul 20168:00 amRNSDirectors Holdings and Total Voting Rights
5th Jul 201611:05 amRNSResult of General Meeting
1st Jul 20167:01 amRNSBlock Listing Interim Return
1st Jul 20167:00 amRNSTotal Voting Rights
29th Jun 20167:00 amRNSPatent update
27th Jun 20167:00 amRNSUpdate on WANdisco OEM sales partnership with IBM
10th Jun 20167:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.